Corvidane is developing Corvida™ to treat TWO formidable diseases. Corvidane uses a novel approach to treat metabolic and inflammatory diseases. Corvida(TM) for Atherosclerosis - In development to be a Best-in-Class, orally administered adjunct to lipid regulating therapies (Statins/PCSK9) that tar...
Use this information to figure out if this company is an ideal customer for you.
212.464.7021
122 Greenwich Avenue
New York, 10011
11 - 50 Employees
$1M - $5M
linkedin.com/company/burke&boyer
The most common Corvidane email format is [first] (ex. john@corvidane.com), currently being used by 100% of Corvidane business email addresses. There are 1 email formats used by Corvidane.
Corvidane's CEO is Damion J Boyer
Corvidane's HQ is located at 122 Greenwich Avenue, New York
Corvidane's phone number is 212.464.7021
Corvidane's official website is corvidane.com
Corvidane's revenue is $1M - $5M
Corvidane has 11 - 50 employees
Corvidane is in the industry of: Pharmaceuticals
